Drug
LEO 27847 clinical trials
Also written LEO 27847.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2009
How studies write it
Studies that test it under each name
Development codes
- LEO 27847
- 3
Studies by the year they started
4 studies that test it; most in 2010 (3)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2010 | 3 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses LEO 27847 is read from its arms, and is right about nine times in ten.
Testing it · 4
- The Impact of Renal Impairment on the Pharmacokinetic and Pharmacodynamic of LEO 27847CompletedPhase 1LEO PharmaNCT01141179Written as LEO 27847
- LEO 27847 - A Study in Healthy Male SubjectsCompletedPhase 1LEO PharmaNCT01007383Written as LEO 27847
- LEO 27847 - Single Dose Bioavailability Study of Oral Solution Versus Tablet in Healthy SubjectsCompletedPhase 1LEO PharmaNCT01143298Written as LEO 27847 oral solution
- LEO 27847 - Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in Secondary Hyperparathyroidism PatientsCompletedPhase 1LEO PharmaNCT01167309Written as LEO 27847